American Society of Addiction Medicine
American Society of Addiction Medicine
Lead First Trimester Use of Buprenorphine or Methadone
Lead First Trimester Use of Buprenorphine or Methadone
Lead First Trimester Use of Buprenorphine or Methadone
Tuesday 30th January 2024
Learn about buprenorphine vs methadone in pregnancy and other key addiction medicine research in this insightful episode.
6 minutes
Informative
Empowering
Hopeful
Supportive
Educational
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
169 (View all)
Do you want to link to this podcast?
Get the buttons here!Pregnancy and Addiction: Choosing Buprenorphine or Methadone
Episode Overview
- Insights into the impact of buprenorphine and methadone on congenital malformations in pregnancy
- Study findings on reduced drug use as a valid outcome for individuals with stimulant use disorders
- Exploration of Alcoholics Anonymous participation and its influence on personal meaningfulness
- Research on the cardiovascular safety of medical cannabis for chronic pain
- Implications of anxiety treatment in youth for substance use disorder prevention
Reduced use was significantly associated with decreases in craving for the primary drug, drug-seeking behaviors, and depression severity. Moreover, reduced use was associated with sustained clinical benefit at follow-up.
Ever wondered how addiction treatments impact pregnancy? This episode of 'This Week in Addiction Medicine' dives into the crucial topic of using buprenorphine and methadone during the first trimester. Host Claire Rasmussen presents eye-opening research showing that buprenorphine might be the safer option for reducing congenital malformations compared to methadone.
The discussion doesn’t stop there; it also touches on other significant studies, such as how reduced drug use can be a valid outcome for stimulant use disorders and the influence of Alcoholics Anonymous on personal meaning. You’ll also hear about the cardiovascular safety of medical cannabis for chronic pain and how treating anxiety in youth could prevent substance use disorders later in life. Intrigued by the rise in medications for opioid use disorder among Louisiana Medicaid enrollees?
This episode covers that too, along with the effectiveness of intranasal naloxone for opioid overdose. Finally, an expert review demystifies the clinical pharmacology of Kratom, offering valuable insights into this controversial substance. Whether you're a healthcare professional, a student, or someone affected by addiction, this episode is packed with information that could make a real difference.